We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$301M
AUM Growth
+$19.7M
Cap. Flow
-$2.64M
Cap. Flow %
-0.88%
Top 10 Hldgs %
38.72%
Holding
58
New
2
Increased
3
Reduced
10
Closed
1

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.16M
2
ALC icon
Alcon
ALC
+$3.89M
3
AMZN icon
Amazon
AMZN
+$3.57M
4
ILMN icon
Illumina
ILMN
+$717K
5
ATR icon
AptarGroup
ATR
+$682K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$5.87M
2
MA icon
Mastercard
MA
+$3.27M
3
BIIB icon
Biogen
BIIB
+$2.79M
4
PEP icon
PepsiCo
PEP
+$1.09M
5
PYPL icon
PayPal
PYPL
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 26.75%
2 Technology 17.73%
3 Industrials 16.76%
4 Communication Services 11.07%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPGP icon
26
IPG Photonics
IPGP
$4.21B
$5.23M 1.74%
36,090
– –
MMM icon
27
3M
MMM
$84B
$4.94M 1.64%
33,488
– –
CVS icon
28
CVS Health
CVS
$137B
$4.4M 1.46%
+59,180
New +$4.16M
RTN
29
DELISTED
Raytheon Company
RTN
$4.39M 1.46%
20,000
– –
LOW icon
30
Lowe's Companies
LOW
$115B
$4.14M 1.38%
34,600
– –
SYK icon
31
Stryker
SYK
$123B
$4.02M 1.34%
19,145
– –
WMT icon
32
Walmart Inc
WMT
$900B
$3.92M 1.3%
99,000
– –
TDOC icon
33
Teladoc Health
TDOC
$1.71B
$3.88M 1.29%
46,345
– –
ALC icon
34
Alcon
ALC
$34.2B
$3.85M 1.28%
+68,008
New +$3.89M
PFE icon
35
Pfizer
PFE
$142B
$3.74M 1.24%
100,657
– –
CL icon
36
Colgate-Palmolive
CL
$73.4B
$3.52M 1.17%
51,200
– –
CMCSA icon
37
Comcast
CMCSA
$85.4B
$3.51M 1.17%
78,000
– –
ZTS icon
38
Zoetis
ZTS
$31.7B
$3.29M 1.09%
24,818
– –
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.35T
$3.02M 1%
45,120
– –
ADBE icon
40
Adobe
ADBE
$91.7B
$2.97M 0.99%
9,000
– –
CSX icon
41
CSX Corp
CSX
$93.5B
$2.46M 0.82%
102,000
– –
XOM icon
42
ExxonMobil
XOM
$616B
$2.17M 0.72%
31,040
-13,000
-30% -$899K
GE icon
43
GE Aerospace
GE
$358B
$2.11M 0.7%
37,980
-12,038
-24% -$622K
AEO icon
44
American Eagle Outfitters
AEO
$2.91B
$1.99M 0.66%
135,460
– –
PEP icon
45
PepsiCo
PEP
$185B
$1.78M 0.59%
13,000
-8,000
-38% -$1.09M
T icon
46
AT&T
T
$152B
$1.56M 0.52%
52,960
– –
FTV icon
47
Fortive
FTV
$18.6B
$1.39M 0.46%
28,782
– –
IFF icon
48
International Flavors & Fragrances
IFF
$19.8B
$1.29M 0.43%
10,000
– –
CI icon
49
Cigna
CI
$75.2B
$1.19M 0.4%
5,841
– –
NVS icon
50
Novartis
NVS
$290B
$882K 0.29%
9,315
– –
1
2
3

Similar funds

RC
RBO & Co Saint Helena, California $620M AUM 4.67% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $620M AUM 16.24% 1-Year Est. Return
KFAS
Keating Financial Advisory Services Manhattan, Kansas $619M AUM
RIS
Richmond Investment Services Mequon, Wisconsin $619M AUM 22.39% 1-Year Est. Return
AMG
Asset Management Group Stamford, Connecticut $619M AUM 15.97% 1-Year Est. Return
BWP
Burling Wealth Partners Chicago, Illinois $618M AUM 17.33% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $618M AUM 8.76% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $618M AUM 60.79% 1-Year Est. Return

Chad R. Baker's Q4 2019 Portfolio in Review

As of Q4 2019, Chad R. Baker held 58 positions worth $301M, up 7% from $281M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker's Q4 2019 filing shows 2 new, 3 increased, 10 reduced and 1 closed positions. Its largest new stake was CVS Health: 59,180 shares worth $4.4M. The largest sale was Johnson & Johnson, an estimated $5.87M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • Chad R. Baker's largest Q4 2019 buy was CVS Health: 59,180 shares worth $4.4M.
  • Chad R. Baker added most to Amazon in Q4 2019, an estimated $3.57M increase.
  • Chad R. Baker's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $5.87M.
  • Chad R. Baker fully exited Biogen in Q4 2019, selling an estimated $2.79M.
  • Chad R. Baker's ten largest holdings make up 39% of its $301M portfolio in Q4 2019.
  • Chad R. Baker opened 2 new positions and closed 1 in Q4 2019.
  • Chad R. Baker's portfolio value rose 7% quarter-over-quarter to $301M.

Based on Chad R. Baker's 13F filing for Q4 2019, filed 12 Feb 2020.